Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
NCT00060320 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 132
Last updated 2016-07-13
Summary
RATIONALE: The herbal supplement black cohosh may be effective in relieving hot flashes in women.
PURPOSE: Randomized phase III trial to determine the effectiveness of black cohosh in relieving hot flashes in women who have breast cancer or who are at risk of developing breast cancer.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
black cohosh
- OTHER
-
placebo
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Alliance for Clinical Trials in Oncology
lead OTHER
Principal Investigators
-
Barbara A. Pockaj, MD · Mayo Clinic Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-10-31
- Primary Completion
- 2006-06-30
- Completion
- 2006-06-30
Countries
- United States
Study Locations
More Related Trials
-
Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women
NCT00056082 ·Status: COMPLETED ·Phase: PHASE2
-
Immediate or Delayed Naturopathic Medicine in Combination With Neo-Adjuvant Chemotherapy for Breast Cancer
NCT02486796 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer
NCT06538389 ·Status: RECRUITING ·Phase: PHASE2
-
Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer
NCT01695226 ·Status: COMPLETED ·Phase: PHASE2
-
Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer
NCT01219075 ·Status: COMPLETED ·Phase: NA
-
Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease
NCT00031720 ·Status: COMPLETED ·Phase: PHASE2
-
Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer
NCT00290758 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer
NCT04298086 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
NCT06917313 ·Status: RECRUITING ·Phase: PHASE2
-
Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women
NCT00186121 ·Status: COMPLETED ·Phase: PHASE2
-
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
NCT00382070 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer
NCT00929591 ·Status: COMPLETED ·Phase: PHASE3
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women
NCT00090857 ·Status: COMPLETED ·Phase: PHASE2
-
Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer
NCT00002580 ·Status: COMPLETED ·Phase: PHASE3
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density
NCT00238316 ·Status: COMPLETED ·Phase: PHASE2
-
Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer
NCT00073073 ·Status: COMPLETED ·Phase: PHASE2
-
Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer
NCT00691509 ·Status: UNKNOWN
-
Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer
NCT00280930 ·Status: UNKNOWN ·Phase: PHASE2
-
Iodine Supplementation on Breast Cancer
NCT03688958 ·Status: UNKNOWN ·Phase: PHASE2
-
Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer
NCT00516243 ·Status: COMPLETED ·Phase: PHASE1
-
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast
NCT03063619 ·Status: COMPLETED ·Phase: PHASE2
-
Melatonin in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT07067307 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Raloxifene in Preventing Breast Cancer in Premenopausal Women
NCT00019500 ·Status: COMPLETED ·Phase: PHASE2
-
Melatonin Versus Placebo in Breast Cancer
NCT01805089 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer
NCT00078832 ·Status: COMPLETED ·Phase: PHASE3